Related Experiment Videos
Dexamethasone-suppressible hyperaldosteronism: a large new kindred
S O'Mahony1, A Burns, D J Murnaghan
1Department of Medicine, Regional Hospital, Cork, Eire.
Journal of Human Hypertension
|August 1, 1989
Summary
Dexamethasone-suppressible hyperaldosteronism (DSH), a rare familial condition, was identified in a large Irish kindred. This genetic hypertension subtype shows mineralocorticoid excess corrected by glucocorticoids, highlighting the importance of family history.
Area of Science:
- Endocrinology
- Genetics
- Cardiovascular Medicine
Background:
- Dexamethasone-suppressible hyperaldosteronism (DSH) is a rare, familial form of primary aldosteronism.
- It is characterized by mineralocorticoid excess that resolves with glucocorticoid therapy.
Observation:
- A large kindred with a history of premature cardiovascular death was studied.
- DSH was confirmed in four members, with evidence of aldosterone excess in two others.
- The syndrome was identified in distant relatives (fourth cousins), indicating strong genetic transmission.
Findings:
- The study documented DSH in a significant portion of the extended family.
- All affected individuals were effectively managed with potassium-sparing diuretics.
- This represents the first documented family with DSH in Ireland.
Implications:
- The findings underscore the critical role of comprehensive family history in diagnosing primary aldosteronism.
- Early identification and management of DSH can prevent severe cardiovascular complications.
- This research expands the understanding of DSH prevalence and genetic patterns in the British Isles.